logo
Plus   Neg
Share
Email

Moderna Regains Rights To Respiratory Syncytial Virus Vaccine From Merck - Quick Facts

Moderna, Inc., (MRNA) said it has regained all rights to the respiratory syncytial virus vaccine (mRNA-1172) from Merck, including rights to develop RSV vaccines for adult populations. Merck will complete the phase 1 study and transition the program to Moderna.

Moderna also announced the initiation of dosing in the phase 1 study of its solely owned RSV vaccine candidate (mRNA-1345). This phase 1 study includes initial dosing in adults, followed by age de-escalation into children.

Moderna and Merck will continue their ongoing collaboration in cancer vaccines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After providing free and discounted rides to the polls on Election Day, Lyft is now set to support voters with discounted rides to the polls for the federal runoff races in Louisiana and Georgia. They also provided similar rides during the primary season. The ride-sharing company is continuing its Voting Access Program to provide affordable transportation to voters in need. Discount retailer Dollar General Corp. and supermarket chain Kroger Co. on Thursday reported sharp increases in their quarterly profits on higher sales. While Dollar General's results trounced analysts' estimates, Kroger's earnings beat expectations while revenue fell short. Dollar General's profit for the third quarter surged 57 percent from last year. On January 4, 2021, Discovery plans to launch its new standalone streaming service called Discovery+ which will also offer exclusive streaming access to the BBC's award-winning natural history shows like Planet Earth, Blue Planet, and Frozen Planet. The channel is expected to offer the largest content of real-life entertainment provided by any streaming platform at launch.
Follow RTT